| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/12/2006 | CN1263750C Heterocyclic sulfonamide inhibitors from beta amyloid |
| 07/12/2006 | CN1263745C Aryl fused azapolycyclic compounds |
| 07/12/2006 | CN1263720C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 07/12/2006 | CN1263514C Fluoro labeled anthracyclinone and anthracycline derivatives |
| 07/12/2006 | CN1263503C 'Changyuan' capsule and preparing technique |
| 07/12/2006 | CN1263497C Chinese medicine for stopping narcotic drug |
| 07/12/2006 | CN1263476C Poisonous element content-decreasing Kawa extracts and its composition and preparing method |
| 07/12/2006 | CN1263465C Copper agonist that binds on the copper binding site of APP and/or exerts an inhibiting effect on the release of anyloid A beta peptide |
| 07/12/2006 | CN1263454C Fosphenytoin sodium powder for injection and its preparation |
| 07/12/2006 | CN1263446C Self emulsifying lipid matrix (SELM) |
| 07/11/2006 | USRE39181 1 mg/ml risperidone or salt, 7.5 mg/ml tartaric acid and sufficient sodium hydroxide buffer to adjust the pH in the range from 3 to 4; and water q.s. ad 1 ml.; suitable for oral adminstration; improved physiochemical stability |
| 07/11/2006 | US7074961 Antidepressants and their analogues as long-acting local anesthetics and analgesics |
| 07/11/2006 | US7074939 Indole derivatives as anti-inflammatory agents |
| 07/11/2006 | US7074929 Certain alkylene diamine-substituted heterocycles |
| 07/11/2006 | US7074925 N-substituted derivatives of 5-oxyiminobarbituric acid |
| 07/11/2006 | US7074924 Compounds as cancer inhibitors in mixtures with other compounds such as methotrextrate |
| 07/11/2006 | US7074915 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof |
| 07/11/2006 | US7074833 Use of the (1S,2R) enantiomer of milnacipran for the preparation of a drug |
| 07/11/2006 | US7074809 Exhibiting an activity at metabotropic glutamate receptors (mGluRs), especially at the mGluR5 receptor |
| 07/11/2006 | US7074808 4-(Phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders |
| 07/11/2006 | US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 07/11/2006 | US7074802 analgesics; antipyretics; antiinflammatory agents; antiarthritic agents |
| 07/11/2006 | US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 07/11/2006 | US7074796 High affinity for D4 receptors; treatment of psychological disorders such as schizophrenia, generalised anxiety disorder, panic disorder, and obsessive compulsive disorder. |
| 07/11/2006 | US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides |
| 07/11/2006 | US7074792 antiserotonine agents; central nervous system disorders; Alzheimer's disease |
| 07/11/2006 | US7074791 Pyrrolo[1,2-b]pyridazine compounds and their uses |
| 07/11/2006 | US7074782 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor |
| 07/11/2006 | US7074780 Substituted phenylcyclohexanecarboxamides and their use |
| 07/11/2006 | US7074773 Pharmaceutical composition for diabetic neuropathy |
| 07/11/2006 | US7074766 antiinflammatory agents; autoimmune diseases; thrombosis; viricides; blood disorders; antitumor agents |
| 07/11/2006 | US7074763 Stable formulations of nerve growth factor |
| 07/11/2006 | US7074614 Clock gene BMAL2 |
| 07/11/2006 | US7074576 Protein biopolymer markers indicative of alzheimer's disease |
| 07/11/2006 | US7074574 Method of detecting growth differentiation factor-7 (GDF-7) using GDF-7 antibodies |
| 07/11/2006 | US7074437 comprises synthetic zeolite, protein extracts of nettle, milk vetch, balm, hop cones, and B-complex vitamins |
| 07/11/2006 | US7074430 Oral administering |
| 07/11/2006 | US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 07/11/2006 | US7074402 Treating different types of neuronal dysfunction, including stroke, Alzheimer's disease, Parkinson's disease, Huntington disease, neuroimmunological disorders such as multiple scelrosis |
| 07/11/2006 | CA2395114C 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 07/11/2006 | CA2376876C New isoindoloindolone derivatives, the process for preparing them and the pharmaceutical compounds that contain them |
| 07/11/2006 | CA2367306C New cycloheptene compounds, their preparation process and the pharmaceutical compounds containing them |
| 07/11/2006 | CA2364718C Monoamine reuptake inhibitors for treatment of cns disorders |
| 07/11/2006 | CA2351658C Anticonvulsant derivatives useful in treating post traumatic stress disorder |
| 07/11/2006 | CA2344255C Novel derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane, process for preparing them and pharmaceutical compositions containing them |
| 07/11/2006 | CA2341375C Extended release buccal bioadhesive tablet |
| 07/11/2006 | CA2319201C Celecoxib compositions |
| 07/11/2006 | CA2285548C Nicotinamide derivatives |
| 07/11/2006 | CA2274074C Novel compounds with analgesic effect |
| 07/11/2006 | CA2262566C Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect |
| 07/11/2006 | CA2227984C Aza-anthracyclinone derivatives |
| 07/11/2006 | CA2198751C Dihydro-2,3-benzodiazepine derivatives |
| 07/11/2006 | CA2157921C Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof |
| 07/11/2006 | CA2090584C Steroids having a methylene lactone group at position 17, process for preparing the same and their intermediates, use of the same as drugs and pharmaceutical compositions comprising the same |
| 07/11/2006 | CA2078549C Multiple sclerosis t-cell receptor |
| 07/06/2006 | WO2006071995A1 Serine amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof |
| 07/06/2006 | WO2006071988A1 Thienopyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 07/06/2006 | WO2006071778A2 Treatment of parkinson's disease and related disorders using postpartum derived cells |
| 07/06/2006 | WO2006071730A1 Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders |
| 07/06/2006 | WO2006071601A2 Therapeutic compositions for intranasal administration of ketorolac |
| 07/06/2006 | WO2006071184A1 Aryl sulphonamide modulators |
| 07/06/2006 | WO2006070943A1 Condensed imidazole compound and use thereof |
| 07/06/2006 | WO2006070927A1 Pyrimidinylisoxazol derivative |
| 07/06/2006 | WO2006070874A1 Hypoxic response promoter |
| 07/06/2006 | WO2006070781A1 Matrix-type controlled release preparation comprising basic substance or salt thereof, and process for production of the same |
| 07/06/2006 | WO2006070742A1 Tolerance development inhibitor for narcotic analgesic agent |
| 07/06/2006 | WO2006070726A1 N-acetylglucosamine tablet disintegrating in oral cavity and process for producing the same |
| 07/06/2006 | WO2006070618A1 Catecholamine regulator and foods, drinks, food additives and drugs containing the same |
| 07/06/2006 | WO2006070394A1 Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors |
| 07/06/2006 | WO2006070284A1 Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors |
| 07/06/2006 | WO2006070106A1 N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid cb1 receptor antagonists |
| 07/06/2006 | WO2006069993A1 Arylpiperazine derivatives and use thereof as 5-ht1a receptor ligands |
| 07/06/2006 | WO2006069809A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments |
| 07/06/2006 | WO2006069808A2 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 07/06/2006 | WO2006069776A1 5-ht7 receptor antagonists |
| 07/06/2006 | WO2006069775A1 5-ht7 receptor antagonists |
| 07/06/2006 | WO2006069419A1 Nanoparticle composition and methods for synthesis thereof |
| 07/06/2006 | WO2006058059A3 Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject |
| 07/06/2006 | WO2006050165A3 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis |
| 07/06/2006 | WO2006047687A3 Compositions and methods for short interfering nucleic acid inhibition of nav1.8 |
| 07/06/2006 | WO2006047251A3 3-alkylaryl aspartate compounds and their use for selective enhancement of synaptic transmission |
| 07/06/2006 | WO2006041985A3 Thienopyridinone compounds and methods of treatment |
| 07/06/2006 | WO2006029838A3 Secreted polypeptide species involved in alzheimer’s disease |
| 07/06/2006 | WO2005116002A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/06/2006 | US20060149072 Selective to alpha2B or alpha2C adrenergic receptors, minimal cardivascular or sedatory activity; treating visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |
| 07/06/2006 | US20060149066 Imidazole derivatives |
| 07/06/2006 | US20060148900 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 07/06/2006 | US20060148898 Curing and prophylactic agent applied during the use of alcohol and psychoactive substances |
| 07/06/2006 | US20060148896 Use of an alkanoyl L-carnitine for the preparation of a medication to treat anhedonia |
| 07/06/2006 | US20060148881 Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-Benzodioxan |
| 07/06/2006 | US20060148856 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 07/06/2006 | US20060148852 Visual function disorder improving agents |
| 07/06/2006 | US20060148850 4-{'3-(Sulfonylamino) phenyl!'1-(cyclymethyl) piperidin-4-ylidene! methyl}benazmide derivativess as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder |
| 07/06/2006 | US20060148844 Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation |
| 07/06/2006 | US20060148840 Pyrrolodihydroisoquinolines as pde10 inhibitors |
| 07/06/2006 | US20060148838 Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
| 07/06/2006 | US20060148835 Mglu receptors antagonists for treating disorders associated with mglu receptors including addiction and depression |
| 07/06/2006 | US20060148831 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 07/06/2006 | US20060148827 administering adenosine receptor antagonist; side effect reduction; Parkinson's disease |
| 07/06/2006 | US20060148825 1-[Alkyl], 1-[(heteroaryl) alkyl] and 1-[(Aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives |